Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 31 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Pylera with omeprazole for treating helicobacter pylori associated ulcers	Omeprazole (Yosprala;PA32540;Omeprazole magnesium;Omeprazole sodium , Pylera (BLI-1300;FP-110;Metronidazole benzoate)	Helicobacter pylori	Gastroenterology	2023	View \| Download
Risankizumab for moderate to severe crohn’s disease	Risankizumab (BI 655066; Skyrizi; ABBV 066)	Crohn's disease	Gastroenterology , Immunology	2021	View \| Download
Risankizumab for moderate to severe ulcerative colitis	Risankizumab (BI 655066; Skyrizi; ABBV 066)	Ulcerative colitis	Gastroenterology	2022	View \| Download
Setmelanotide for obesity in Bardet-Biedl syndrome and Alstrom syndrome	Setmelanotide (RM-493)	Hyperphagia , Obesity	Endocrine Nutritional and Metabolic Disorders , Gastroenterology , Genetic Disorders	2021	View \| Download
Teduglutide for short bowel syndrome in infants	Teduglutide	Short bowel syndrome	Gastroenterology	2022	View \| Download
Tenapanor for Irritable Bowel Syndrome with Constipation	Tenapanor (AZD1722; RDX5791; Ibsrela)	Irritable bowel syndrome with predominant constipation (IBS-C)	Gastroenterology	2018	View \| Download
Upadacitinib for moderate to severe active Crohn’s disease	Upadacitinib (ABT-494; Rinvoq; upadacitinib hemihydrate)	Crohn's disease	Gastroenterology , Immunology	2021	View \| Download
Upadacitinib for ulcerative colitis	Upadacitinib (ABT-494; Rinvoq; upadacitinib hemihydrate)	Ulcerative colitis	Gastroenterology	2021	View \| Download
Ustekinumab for Moderately to Severely Active Ulcerative Colitis	Ustekinumab (Stelara; CNTO 1275; CNTO-1275)	Ulcerative colitis	Gastroenterology	2018	View \| Download
Ustekinumab for the treatment of moderately to severely active Crohn's disease in children	Ustekinumab (Stelara; CNTO 1275; CNTO-1275)	Crohn's disease	Gastroenterology , Immunology	2023	View \| Download